FTC, States Ask Federal Court to Hold Martin Shkreli in Contempt for Allegedly Violating Lifetime Ban from Pharmaceutical Industry

14 October 2026

Commission cites evidence it alleges shows that Shkreli repeatedly violated a 2022 order that banned him from working in the pharmaceutical industry for life

The Federal Trade Commission and seven states today asked a federal judge to hold Martin Shkreli in contempt based on their allegations that he flagrantly and repeatedly violated a 2022 court order that banned him from the pharmaceutical industry.

View Press Release